In complex clinical environments, even well‑designed strategies can drift from prescribing reality. Pathways are less linear, stakeholder influence is broader, and confidence to act varies widely across settings. Advisory Boards play a vital role in closing that gap, but only when they are designed to uncover genuine insight rather than confirm existing thinking.
In this Q&A, Studio Business Director, Emma Morriss, shares what makes Advisory Boards impactful in 2026, from asking the right questions and structuring discussions for insight, to turning outputs into meaningful action across the brand lifecycle.
Why are Advisory Boards important in the strategic planning?
Advisory Boards are a valuable tool in complex clinical environments. As the market becomes more competitive, prescribing decisions are based on a multitude of factors and the patient pathway is less linear, a gap can grow between your strategic approach and the prescribing reality. This makes Advisory Boards an effective way to gain real-world insight from key stakeholders who have relevant expertise.
How do you make sure Advisory Boards generate strategic insight, not simple validation?
Most clients start with a challenge or a situation that needs insight, and although they may not be considering an advisory board, it can be the right method for gaining the clarity they need. Starting with the exact challenge being faced and what has been done to address it helps you ensure that the meeting produces insight, not just agreement with your thinking.
Structuring the Advisory Board around this then allows for open conversation. You need a strong agenda that sets the situation and allows time for all stakeholders to explore the challenge and bring different perspectives. This is why it is critical to get the right people in attendance. You need a mix of voices from different areas such as specialists, prescribers, nurses and payers, if relevant, to have genuine exploratory conversations.
And then let them talk. The gold comes from the open conversation. Set the scene, pose the questions and let them discuss. We find that a level of pre-work – interviews or questionnaires –gives good insight into the expertise, position or knowledge that will be in the room. And pre-reading can help ensure that everyone has a base understanding before joining.
How can Advisory Boards add value across the whole brand lifecycle, from early strategic planning right through to post‑launch optimisation?
Advisory Boards are synonymous with product launches. They give valuable insight, but they also have a place throughout the brand lifecycle. In early strategic planning you gain an understanding of unmet need, current practice and pathways, the evidence needs of decision-makers, and identify barriers before you finalise your launch plan. It allows you to understand clinical confidence, treatment sequencing, service pressures, pathway fit or information needs that may affect your launch readiness.
Post-launch they give you the opportunity to explore any specific challenges that you may be experiencing. For example, why uptake is not as expected, why certain segments are not responding, where access is an issue, and understanding what is influencing decision-making at a local level – as well as uncovering evidence or education gaps.
Then later in the lifecycle or towards loss of exclusivity, Advisory Boards can be valuable in allowing you to understand perception and position amongst clinicians or whether service redesign or pathway review are required in a changing market.
The constant is the need for insight, wherever the brand sits in the lifecycle.
How do you turn Advisory Board insights into actions?
An Advisory Board is the starting point, not the end. The discussion is so valuable, but the insight needs action. That means the reporting should capture key themes, tensions, barriers, evidence gaps and next steps to overcome them. Outputs should be objective and you need clear ownership, whether that’s medical, commercial, market access, patient services or cross-functional teams.
It’s important to note that Advisory Boards inform strategic decisions not promotional activity. You gain clarity to inform future activities, whether that’s evidence generation, medical communications or medical education programmes, engagement strategies, access planning or resource deployment. The insights change how you respond.
How do I know that my Advisory Board is “asking the right questions”?
Developing an advisory board is about delving into the unknowns to get the answers. You need a good facilitator who will keep the conversation heading in the right direction. Is what is being said the same for all clinicians? What is their reality?
Conversations can feel challenging for the client in the room. There may be hard truths, but hearing them, understanding them and then putting actions in place to address them is what is needed.
How do you strike a balance between compliance and meaningful discussions?
Compliance is not there to prevent discussion, but to ensure it is legitimate, valid and based on real need. An experienced agency partner has the skills and experience to ensure compliance is adhered to, attendees are managed within code requirements, and the event is clearly non-promotional.
As for question development, the right partner and facilitator will shape them with you to ensure you’re not confirming your narrative, but that you’re delving into their real experiences in your therapy area, with your target stakeholders. The facilitator will then frame the meeting around open discussion and honest contribution, ensuring all voices are heard and the flow is grounded in the objectives.
How have Advisory Boards evolved in response to how HCPs want to interact?
Advisory Board formats have evolved and are now frequently run in virtual, in-person or hybrid formats to allow for wider participation. When you’re looking at a geographic split of attendees, it can be easier to run in virtual or hybrid. The facilitation of virtual or hybrid Advisory Boards has become more important to ensure everyone feels engaged and included, and it can yield great conversation and insight.
Mixed stakeholder groups and more flexible models to allow for participation also work well, with clinicians who may not be available on the day but would like to add voice to the conversation, being able to submit their written or offline insight for consideration and discussion on the day or in the reporting.
Do you see Advisory Boards adding value to omnichannel plans and content strategies?
Yes, without doubt. We have been able to create targeted HCP engagement from the outputs of an Advisory Board. But it’s important the meeting is not disguised as a content planning exercise. It is the insight that informs future engagement or educational strategy.
If you had to sum it up, what truly makes an Advisory Board impactful rather than just a tick‑box exercise?
Strong, actionable output. Holding the event ticks the box, but the insights can change the understanding of the business.
Want to discuss how to get the most out of your Advisory Board? Get in contact with us today.
